New Haven, CT · Founded 2023 · Privately Held (backing)
Developer of a Ribonucleic Acid (RNA) therapeutics development platform designed to revolutionize cancer therapy and patient outcomes in oncology. Cloverleaf Bio is based in New Haven, CT and was founded in 2023. It has raised $1.1 million.
Last price · $/share
—
Implied valuation
—
Total raised
$1.1M
Last round
—
Team — not yet on record
No current team members for Cloverleaf Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Cloverleaf Bio with a free Private Market View account
·Watch Cloverleaf Bio: the Monday email on marks, rounds and moves
